|
|
|
|
| LEADER |
00819Cim#a2200253#a#4500 |
| 001 |
OMD008458 |
| 003 |
OMD |
| 005 |
20141117103949 |
| 008 |
061002t2002||||xxu| ||| |||||||eng d |
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a WB
|b 310
|
| 092 |
# |
# |
|c WB 310
|l MYL
|
| 245 |
0 |
0 |
|a Mylotarg :
|b gemtuzumab ozogamicin fore injection : slide pprogram /
|c edited by Wyeth Pharmaceuticals.
|
| 260 |
# |
# |
|a Philadelphia :
|b Wyeth,
|c c2002.
|
| 300 |
# |
# |
|a 1 CD-ROM
|
| 505 |
# |
# |
|a El contenido del CD está en Inglés
|
| 650 |
# |
7 |
|a CD-ROM
|2 Decs
|
| 650 |
# |
7 |
|a Leucemia
|2 Decs
|
| 650 |
# |
7 |
|a Tratamiento paliativo
|2 Decs
|
| 710 |
2 |
# |
|a Wyeth Pharmaceuticals,
|e editor.
|
| 866 |
# |
0 |
|a 2 ej.
|
| 952 |
# |
# |
|w 061002
|p OMDCD127
|t ej.1
|a OMD
|b OMD
|o WB 310 MYL [SALA]
|7 1
|y CDR
|
| 952 |
# |
# |
|w 061002
|p OMDCD136
|t ej.2
|a OMD
|b OMD
|o WB 310 MYL [PRESTAMO]
|y CDR
|
| 999 |
# |
# |
|a Sandra
|